Published in Hepatogastroenterology on December 01, 1993
Effects of High FIO2 on Post-ERCP Pancreatitis. | NCT04876768
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med (2012) 4.51
Natural course of acute pancreatitis. World J Surg (1997) 2.48
Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci U S A (1998) 1.90
Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction. Dig Dis Sci (1997) 1.57
The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut (1997) 1.54
Can Rectal Diclofenac Prevent Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis? Dig Dis Sci (2015) 1.43
Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg (1996) 1.17
Experimental study of Tong Xia purgative method in ameliorating lung injury in acute necrotizing pancreatitis. World J Gastroenterol (2000) 1.06
Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial. J Gastroenterol (2012) 1.03
Pathophysiology of pulmonary complications of acute pancreatitis. World J Gastroenterol (2006) 1.02
Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: protease inhibitors and NSAIDs in a meta-analysis. J Gastroenterol (2013) 1.02
Serum interleukin 10 and interleukin 11 in patients with acute pancreatitis. Gut (1999) 0.97
Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis. Dig Dis Sci (1998) 0.97
Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis. Gut (2000) 0.95
Lipopolysaccharide directly affects pancreatic acinar cells: implications on acute pancreatitis pathophysiology. Dig Dis Sci (2000) 0.91
Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial. World J Gastroenterol (2016) 0.91
alpha2-macroglobulin- and murinoglobulin-1- deficient mice. A mouse model for acute pancreatitis. Am J Pathol (1999) 0.90
Gardenia jasminoides protects against cerulein-induced acute pancreatitis. World J Gastroenterol (2008) 0.90
Technetium-99m-labeled white blood cells: a new method to define the local and systemic role of leukocytes in acute experimental pancreatitis. Ann Surg (1998) 0.89
Efficacy of intramuscular diclofenac and fluid replacement in prevention of post-ERCP pancreatitis. World J Gastroenterol (2009) 0.88
Catalpol ameliorates sodium taurocholate-induced acute pancreatitis in rats via inhibiting activation of nuclear factor kappa B. Int J Mol Sci (2014) 0.87
How and when should NSAIDs be used for preventing post-ERCP pancreatitis? A systematic review and meta-analysis. PLoS One (2014) 0.86
Post-endoscopic retrograde cholangio-pancreatography pancreatitis: is time for a new preventive approach? World J Gastroenterol (2012) 0.84
Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats. World J Gastroenterol (2007) 0.82
Scolopendra subspinipes mutilans protected the cerulein-induced acute pancreatitis by inhibiting high-mobility group box protein-1. World J Gastroenterol (2013) 0.79
Immunological changes of mild acute pancreatitis in late-stage alcoholic chronic pancreatitis. Dig Dis Sci (1999) 0.79
Inhibitory effect of Patrinia scabiosaefolia on acute pancreatitis. World J Gastroenterol (2006) 0.79
Preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: what can be done? World J Gastroenterol (2015) 0.78
Ascites of severe acute pancreatitis in rats transcriptionally up-regulates expression of interleukin-6 and -8 in vascular endothelium and mononuclear leukocytes. Dig Dis Sci (2000) 0.78
Adjuvant treatment of severe acute pancreatitis with C1 esterase inhibitor concentrate after haematopoietic stem cell transplantation. Gut (1999) 0.78
25 mg versus 50 mg dose of rectal diclofenac for prevention of post-ERCP pancreatitis in Japanese patients: a retrospective study. BMJ Open (2015) 0.78
Neutrophil engagement and septic challenge in acute experimental pancreatitis in rats. World J Gastroenterol (2005) 0.77
Indomethacin for post-endoscopic retrograde cholangiopancreatography pancreatitis prophylaxis: is it the magic bullet? World J Gastroenterol (2012) 0.77
Effect of diclofenac on the levels of lipoxin A4 and Resolvin D1 and E1 in the post-ERCP pancreatitis. Dig Dis Sci (2014) 0.77
Protective effects of emodin combined with danshensu on experimental severe acute pancreatitis. Inflamm Res (2009) 0.77
Role of Rectal Diclofenac Suppository for Prevention and Its Impact on Severity of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients. Gastroenterology Res (2016) 0.76
Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study. Korean J Intern Med (2015) 0.75
Intravenous injection of low-dose flurbiprofen axetil for preventing post-ERCP pancreatitis in high-risk patients: An interim analysis of the trial. Endosc Int Open (2016) 0.75
Protective Effects of Lithospermum erythrorhizon Against Cerulein-Induced Acute Pancreatitis. Pancreas (2015) 0.75
NSAIDs and Acute Pancreatitis: A Systematic Review. Pharmaceuticals (Basel) (2010) 0.75
Contrast-enhanced computed tomography in acute pancreatitis: does contrast medium worsen its course due to impaired microcirculation? Langenbecks Arch Surg (2005) 0.75
Interleukin-6: An Early Predictive Marker for Severity of Acute Pancreatitis. Indian J Crit Care Med (2017) 0.75
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (1996) 4.54
Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology (1998) 3.82
European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut (2006) 3.57
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology (1992) 3.17
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology (1993) 2.83
Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol (2006) 2.81
Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet (1995) 2.81
Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology (2002) 2.80
Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. BMJ (1999) 2.28
Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol (1997) 2.20
Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol (1999) 1.97
Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut (2005) 1.95
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun (2001) 1.94
Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial. Endoscopy (1998) 1.83
Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. J Clin Oncol (2000) 1.77
Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut (1996) 1.73
Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease. Eur J Clin Invest (1999) 1.71
Isolation and phenotypic characterization of colonic macrophages. Clin Exp Immunol (1998) 1.68
Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta (2005) 1.66
Detection of dysplastic lesions by fluorescence in a model of colitis in rats after previous photosensitization with 5-aminolaevulinic acid. Endoscopy (1998) 1.62
Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology (1991) 1.61
A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology (1990) 1.60
Hair iron content: possible marker to complement monitoring therapy of iron deficiency in patients with chronic inflammatory bowel diseases? Clin Chem (1996) 1.56
The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J (2000) 1.52
Hierarchical cleavage of focal adhesion kinase by caspases alters signal transduction during apoptosis of intestinal epithelial cells. Gastroenterology (2001) 1.52
Surface phenotype analysis of human monocyte to macrophage maturation. J Leukoc Biol (1990) 1.52
Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases. Arthritis Rheum (2002) 1.51
Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia. Infection (2010) 1.50
Use of self-expandable plastic stents for the treatment of esophageal perforations and symptomatic anastomotic leaks. Endoscopy (2004) 1.49
Hepatitis C - contamination of toothbrushes: myth or reality? J Viral Hepat (2006) 1.48
Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology (1999) 1.47
Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol (1997) 1.45
Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis. Clin Exp Immunol (2003) 1.45
Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization. Gastrointest Endosc (1999) 1.45
Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis. Am J Gastroenterol (1998) 1.45
Atrial natriuretic factor and digoxin-like immunoreactive factor in diabetic patients: their interrelation and the influence of the autonomic nervous system. J Clin Endocrinol Metab (1996) 1.43
[Fatal liver failure after corticosteroid treatment of a hepatitis B virus carrier]. Dtsch Med Wochenschr (1999) 1.43
Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol (1997) 1.42
Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev (2006) 1.41
Early shifts of adrenal steroid synthesis before and after relief of short-term cholestasis. J Hepatol (2001) 1.41
Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab (1998) 1.40
[Infections and vasculitis]. Z Rheumatol (1997) 1.40
Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum (1999) 1.39
[Chronic inflammatory bowel diseases: Crohn disease and ulcerative colitis. 1: Etiology and pathogenesis, diagnosis. Diagnostic imaging in Crohn disease]. Radiologe (2000) 1.39
[A 63-year-old patient with worsening general condition, bone demineralization, hypocalcemia and excess parathyroid hormone: late manifestations of pseudohypohyperparathyroidism]. Dtsch Med Wochenschr (1999) 1.39
Wound healing and fibrosis in intestinal disease. Gut (2007) 1.38
The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol (2000) 1.33
Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol (2007) 1.33
Association between serum ferritin and the insulin resistance syndrome in a representative population. Eur J Endocrinol (2006) 1.28
Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J Clin Endocrinol Metab (2000) 1.25
Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties--studies on isolated hepatocytes and lipid membrane vesicles. Hepatology (1984) 1.25
Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast cultures. Scand J Gastroenterol (2001) 1.24
Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. Cancer Res (1990) 1.23
Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut (1997) 1.23
Apoptotic signaling during initiation of detachment-induced apoptosis ("anoikis") of primary human intestinal epithelial cells. Cell Growth Differ (2001) 1.18
Alterations of the phenotype of colonic macrophages in inflammatory bowel disease. Eur J Gastroenterol Hepatol (1997) 1.15
Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest (1992) 1.14
Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium. Ann Rheum Dis (2005) 1.14
Nuclear factor-kappa B activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin. Clin Exp Immunol (2000) 1.12
Dengue virus infection transmitted by needle stick injury. J Infect (2002) 1.12
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum (2001) 1.11
The Pro115Gln polymorphism within the PPAR gamma2 gene has no epidemiological impact on morbid obesity. Exp Clin Endocrinol Diabetes (2002) 1.10
Inducible CD40 expression mediates NFkappaB activation and cytokine secretion in human colonic fibroblasts. Gut (2003) 1.10
The role of the sympathetic nervous system in intestinal inflammation. Gut (2006) 1.10
Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice. Eur Cytokine Netw (2000) 1.10
[Diverticular disease]. Dtsch Med Wochenschr (1996) 1.08
[A 36-year old female patient presenting with hypoglycemic coma]. Internist (Berl) (2009) 1.08
Clinical and histopathological features of dextran sulfate sodium induced acute and chronic colitis associated with dysplasia in rats. Int J Colorectal Dis (2001) 1.08
Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis. Clin Exp Immunol (2005) 1.07
Functional expression of the chemokine receptor CCR7 on fibroblast-like synoviocytes. Rheumatology (Oxford) (2008) 1.06
Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin. Dig Dis Sci (1990) 1.06
Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. Exp Clin Endocrinol Diabetes (2003) 1.06
Stress and rheumatic diseases. Rheum Dis Clin North Am (2000) 1.05
Cathepsin D is up-regulated in inflammatory bowel disease macrophages. Clin Exp Immunol (2004) 1.05
Identification of differentially expressed genes in rheumatoid arthritis by a combination of complementary DNA array and RNA arbitrarily primed-polymerase chain reaction. Arthritis Rheum (2002) 1.05
Gene expression pattern of laser microdissected colonic crypts of adenomas with low grade dysplasia. Gut (2003) 1.05
Prevalence of markers of hepatitis B in the adult German population. J Med Virol (2001) 1.04
Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6. Gut (2000) 1.02
Long-term effects of chondrospheres on cartilage lesions in an autologous chondrocyte implantation model as investigated in the SCID mouse model. Int J Mol Med (2009) 1.02
Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study. Rheumatology (Oxford) (2004) 1.02
Regulation of interleukin-8 production in a human colon epithelial cell line (HT-29). Gastroenterology (1995) 1.01
Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol (2004) 1.01
The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. Rheumatology (Oxford) (2000) 1.00
Identification of regulatory elements in the human adipose most abundant gene transcript-1 ( apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways. Diabetologia (2002) 1.00
Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J Leukoc Biol (2000) 1.00
Subtractive screening reveals up-regulation of NADPH oxidase expression in Crohn's disease intestinal macrophages. Clin Exp Immunol (2001) 0.99
Characterization of bile salt-induced apoptosis in colon cancer cell lines. Cancer Res (2000) 0.99